The 2022 Antibodies and Next Generation Therapeutics US event took place in December in San Diego, CA. Featuring the latest science and research on antibody engineering, design and selection diving into critical topics including immuno-oncology, cellular engagers, miniproteins, the Fc region, cancer therapy, novel bi-specifics/multispecifics and much more!
Attendees found thought-leaders and partners from discovery, financing, manufacturing, and clinical trials, to help drive their success. Biopharmaceutical industry journalist, Gareth Macdonald reports on key talks from the event. Including special insights from Beckman Coulter, Alloy Therapeutics, and Genscript Probio